2 ms·
This. US - for example - might solve most of it's expensive drugs problem by simply licensing all relevant IP to India for a guarantee that they would be able
by mordae 4y ago
This.
US - for example - might solve most of it's expensive drugs problem by simply licensing all relevant IP to India for a guarantee that they would be able to buy the drugs with up to 20% profit for the Indian seller after shipping, close an international deal, establish arbitrage and watch drug prices fall to <10% over a decade while Indians build up.
If they established a mutual research fund (possibly with EU and British ex-colonies), they would exceed the current rate of research at 70% of current funding (if the research is kept in the west, basically guaranteed saving - 30% feeds profits and marketing), but if they were to exploit lower Indian wages...
But this will never happen, because US is literally a business-interest device nowadays.
- lapinot 4y agoYeah, i agree, but still, i believe we should even aim for higher standards than what you propose: actually licensing current relevant IP is not enough. At least in the sense that we actually have to develop IP that is small-scale operable, easily shareable, etc. Current techniques are mainly geared toward large scale, investment heavy and resource exploitative applications. It's a start to at least be open about these techniques and share them, but like the article i shared above explained, if you're sharing monoculture technology, you're actually not giving away resilience and robustness. Tons of our current technology has to be reevaluated because it optimized the wrong things.